指南与共识甲状腺疾病

远程入路甲状腺与甲状旁腺手术:2025年国际共识声明

Remote-Access Thyroidectomy and Parathyroidectomy: A 2025 Consensus Statement from the Asia-Pacific Society of Thyroid Surgery, American Head and Neck Society, American Association of Endocrine Surgeons, American Thyroid Association, European Society of Endocrine Surgeons, and Latin American Thyroid Society.
指南 / 共识 · Thyroid · 2025-10-24

该国际共识由六大学会专家采用改良Delphi流程制定,共形成23条共识声明,涵盖术者最低手术量要求、结构化培训路径(包括尸体解剖与带教)及基于疾病特征的患者准入标准。共识指出,在经验丰富术者操作下,四种常用远程入路(经口腔、无充气腋窝、双侧腋窝乳晕及耳后)的肿瘤学与手术结局与开放手术相当,且美容满意度显著改善,但需注意入路特异性并发症和手术时间延长。

要点

  • 远程入路甲状腺/甲状旁腺手术在经验丰富术者中肿瘤学与手术结局与开放手术相当。
  • 共识推荐术者最低手术量要求及结构化培训路径(含尸体解剖与带教)。
  • 四种常用远程入路各有优劣,需关注入路特异性并发症和手术时间延长。

核心结论

  • 该国际共识声明为远程入路甲状腺与甲状旁腺手术的安全有效实施提供了结构化、循证的建议。

研究设计与样本

  • 由六大学会提名专家组成专家组,采用改良Delphi流程,共识定义为5点Likert量表上≥80%同意。

主要发现

  • 共建立23条共识声明,涵盖术者最低手术量要求、结构化培训路径和基于疾病特征的患者准入标准。
  • 四种最常用的远程入路——经口腔、无充气腋窝、双侧腋窝乳晕和耳后——各自具有 distinct 优势和局限性。
  • 在经验丰富术者操作下,这些技术的肿瘤学与手术结局与开放手术相当,美容满意度显著改善。
  • 共识承认了入路特异性并发症和手术时间延长的问题。
  • 强调了知情同意和建设高容量卓越中心的重要性。

关键数值与推荐

  • 共识定义为5点Likert量表上≥80%同意。
  • 共形成23条共识声明。
  • 推荐了术者最低手术量要求。
  • 推荐了结构化培训路径,包括尸体解剖和带教。
  • 推荐了基于疾病特征的患者准入标准。

临床怎么用

  • 临床开展远程入路甲状腺与甲状旁腺手术应遵循共识推荐的术者最低手术量要求和结构化培训路径。
  • 选择患者时应基于疾病特征评估准入标准,并充分告知入路特异性并发症和手术时间延长风险。
  • 建议在经验丰富术者操作下开展,并推动建设高容量卓越中心以促进标准化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Remote-access thyroid and parathyroid surgery has emerged as a safe and effective alternative to conventional transcervical approaches, particularly valued for its superior cosmetic outcomes. However, global adoption remains inconsistent, hindered by variability in clinical indications, geographic and economic factors, learning curves, and training infrastructure. This international consensus statement aims to provide comprehensive, evidence-based guidance on patient selection, surgeon training, surgical approaches, and expected outcomes. An expert panel was convened with representatives nominated by six leading international societies The Asia-Pacific Society of Thyroid Surgery, American Head and Neck Society, American Association of Endocrine Surgeons, American Thyroid Association, European Society of Endocrine Surgeons, and Latin American Thyroid Society. A modified Delphi process, consistent with Conducting and Reporting of Delphi Studies guidelines, was used. Expert subgroups performed targeted literature reviews and formulated recommendations, which were refined through multiple rounds of anonymous electronic voting. Consensus was defined a priori as ≥80% agreement on a 5-point Likert scale. Summary: A total of 23 consensus statements were established. These include recommendations on minimum surgeon volume requirements, structured training pathways (including cadaveric dissection and proctoring), and patient eligibility based on disease characteristics. The four most commonly utilized remote-access approaches-transoral, gasless transaxillary, bilateral axillo-breast, and retroauricular-each offer distinct advantages and limitations. With an experienced surgeon, these techniques demonstrate oncologic and surgical outcomes comparable with open surgery, with notable improvements in cosmetic satisfaction. Approach-specific complications and extended operative times were acknowledged. The importance of informed consent and the development of high-volume centers of excellence was emphasized. Conclusions: This international consensus statement provides structured, evidence-informed recommendations to support the safe and effective implementation of remote-access thyroid and parathyroid surgery. Widespread dissemination and adoption of these recommendations may improve patient outcomes and promote global standardization of care.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Russell JO, Tae K, Roth MY, et al. Remote-Access Thyroidectomy and Parathyroidectomy: A 2025 Consensus Statement from the Asia-Pacific Society of Thyroid Surgery, American Head and Neck Society, American Association of Endocrine Surgeons, American Thyroid Association, European Society of Endocrine Surgeons, and Latin American Thyroid Society. Thyroid. 2025. PMID: 41173534. doi:10.1177/10507256251388410

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。